Stimulation of macrophages with mitochondrial DNA from T2D patients triggers the release of IL‐1β and IL‐18, which is dependent on the AIM2 inflammasome18 (Figure 4B). This evidence concerns the gene IL18 and type 2 diabetes mellitus.